CHEN Zhongwei,ZHAO Youfan,YE Qiong, et al. Assessment of the ability of computed diffusion-weighted imaging to improve the conspicuousness of brain tumors[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2018, 48(10): 769-772.
Abstract:Objective: To assess the ability of computed diffusion-weighted imaging (cDWI) to improve the conspicuousness of brain tumors. Methods: Twenty-four patients with brain tumors (15 male and 9 female, ranging from 13 to 73 in age) who had undergone multi-parameters MRI examinations at 3.0T followed by surgery with the interval less than one month were included in this study. 2 b values DWI was used to synthesize images acquired by computed diffusion weighted imaging (cDWI) at b values of 1 500, 2 000, 2 500, 3 000, 3 500, 4 000 s/mm2. Regions of interest (ROIs) were placed on tumor lesions, peritumoral edema regions and normal-appearing white matter regions, respectively. The signal intensity of ROIs were measured and compared. The contrast ratio (CR) between tumor lesions and normal-appearing white matter regions (CRn) and that between tumor lesions and peritumoral edema regions (CRe) in cDWI images were both compared with measured DWI images. Results: The standardized contrast ratios between tumor and peritumoral edema in cDWI images at b values of 2 500, 3 000, 3 500 and 4 000 s/mm2 were significantly higher than that in measured DWI images at b values of 1 000 s/mm2 (mDWI 1 000) (P<0.05). Conclusion: The high b-value cDWI images could enhance the contrast between brain tumor and the peritumoral edema regions, which has showed potential for the detection of peritumoral invasion of malignant tumor.
[1] KADOTA Y, HIRAI T, NAKAMURA H, et al. Benefit of 3T diffusion-weighted imaging in comparison to contrast-enhanced MR imaging for the evaluation of disseminated lesions in primary malignant brain tumors[J]. Magn Reson Med Sci, 2017, 16(3): 217-222.
[2] ONISHI S, HIROSE T, TAKAYASU T, et al. Advantage of high b value diffusion-weighted imaging for differentiation of hemangioblastoma from brain metastases in posterior fos-sa[J]. World Neurosurg, 2017, 101: 643-650.
[3] YAMASAKI F,KURISU K,AOKI T, et al. Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment[J]. Eur J Radiol, 2012, 81(10): 2805-2810.
[4] ZENG Q, DONG F, SHI F, et al. Apparent diffusion coefficient maps obtained from high b value diffusion-weighted in the preoperative evaluation of gliomas at 3T: comparison with standard b value diffusion-weighted imaging[J]. Eur Radiol, 2017, 27(12): 5309-5315.
[5] KOLAKSHYAPATI M, ADHIKARI R B, KARLOWEE V, et al. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator[J]. J Neurosurg, 2018, 128 (3): 667-678.
[6] HAN C, ZHAO L, ZHONG S, et al. A comparison of high b-value vs standard b-value diffusion-weighted magnetic resonance imaging at 3.0T for medulloblastomas[J]. Br J Radiol, 2015, 88(1054): 20150220.
[7] MARDOR Y, ROTH Y, OCHERSHVILLI A, et al. Pretreatment prediction of brain tumors’ response to radiation therapy using high b-value diffusion-weighted MRI[J]. Neoplasia, 2004, 6(2): 136-142.
[8] CHU H H, CHOI S H, RYOO I, et al. Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging[J]. Radiology, 2013, 269(3): 831-840.
[9] BLACKLEDGE M D, LEACH M O, COLLINS D J, et al. Computed diffusion-weighted MR imaging may improve tumor detection[J]. Radiology, 2011, 261(2): 573-581.
[10] GATIDIS S, SCHMIDT H, MARTIROSIAN P, et al. Apparent diffusion coefficient-dependent voxelwise computed diffusion-weighted imaging: An approach for improving SNR and reducing T2 shine-through effects[J]. J Magn Reson Imaging, 2016, 43(4): 824-832.
[11] MAAS M C, FUTTERER J J, SCHEENEN T W. Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate[J]. Invest Radiol, 2013, 48(11): 779-786.
[12] YOSHIDA R, YOSHIZAKO T, KATSUBE T, et al. Computed diffusion-weighted imaging using 1.5-T magnetic resonance imaging for prostate cancer diagnosis[J]. Clin Imaging, 2017(41): 78-82.
[13] FEUERLEIN S, DAVENPORT M S, KRISHNARAJ A, et al.
Computed high b-value diffusion-weighted imaging improves lesion contrast and conspicuity in prostate cancer [J]. Prostate Cancer Prostatic Dis, 2015, 18(2): 155-160.
[14] TAMURA T, USUI S, MURAKAMI S, et al. Comparisons of multi b-value DWI signal analysis with pathological specimen of breast cancer[J]. Magn Reson Med, 2012, 68(3): 890-897.
[15] FUKUKURA Y, KUMAGAE Y, HAKAMADA H, et al. Computed diffusion-weighted MR imaging for visualization of pancreatic adenocarcinoma: Comparison with acquired diffusion-weighted imaging[J]. Eur J Radiol, 2017, 95: 39-45.
[16] OGURA A, KOYAMA D, HAYASHI N, et al. Optimal b Values for Generation of Computed High-b-Value DW Im-ages[J]. AJR Am J Roentgenol, 2016, 206(4): 713-718.
[17] BURDETTE J H, DURDEN D D, ELSTER A D, et al. High b-value diffusion-weighted MRI of normal brain[J]. J Comput Assist Tomogr. 2001, 25(4): 515-519.
[18] DELANO M C,COOPER T G, SIEBERT J E, et al. High-b-value diffusion-weighted MR imaging of adult brain: image contrast and apparent diffusion coefficient map features[J]. AJNR Am J Neuroradiol, 2000, 21(10): 1830-1836.
[19] ZENG Q, LING C, SHI F, et al. Glioma infiltration sign on high b-value diffusion-weighted imaging in gliomas and its prognostic value[J]. J Magn Reson Imaging, 2018, 1. DOI: 10.1002/jmri.25986. [Epub ahead of print]
[20] MCGIRT M J, CHAICHANA K L, ATTENELLO F J, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas[J]. Neurosurgery, 2008, 63(4): 700-707.